Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Accounts Receivable, Allowance for Credit Loss, Current	$ 5	$ 5
Common stock, shares authorized (in shares)	1,200,000,000	1,200,000,000
Common Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred Stock, Shares Issued	1,043,050	1,043,050
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Accounts receivable, net of allowance for doubtful accounts of $5 and $5, respectively	$ 5	$ 5
Other intangible assets, net of accumulated amortization of $415 and $385, respectively	415	385
Other Noncurrent Assets, Allowance	$ 57	$ 23
Preferred Stock, Shares Outstanding	1,043,050	1,043,050
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued (in shares)	818,790,001	818,717,043
Common stock, shares outstanding (in shares)	667,949,778	666,793,625
Treasury stock, shares (in shares)	150,840,223	151,923,418
Variable Interest Entity [Line Items]
Non-recourse debt, including $321 and $302, respectively, related to variable interest entities	$ 2,007	$ 1,367
Non-recourse debt, including $2,167 and $2,223, respectively, related to variable interest entities	15,530	13,603
Consolidated Variable Interest Entities [Member]
Variable Interest Entity [Line Items]
Non-recourse debt, including $321 and $302, respectively, related to variable interest entities	321	302
Non-recourse debt, including $2,167 and $2,223, respectively, related to variable interest entities	$ 2,167	$ 2,223